Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mobin Karimi

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancer Immunology, Immunotherapy : CII|December 23, 2022
TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responsesRebecca Harris, Mahinbanu Mammadli, Shannon Hiner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cellsMobin Karimi, Thai M Cao, Jeanette A Baker, et al.
Blood|June 21, 2008
In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activityRyosei Nishimura, Jeanette Baker, Andreas Beilhack, et al.
Clinical and Translational Medicine|December 17, 2021
Interleukin-2-inducible T-cell kinase (Itk) signaling regulates potent noncanonical regulatory T cellsMahinbanu Mammadli, Rebecca Harris, Liye Suo, et al.
Cancers|August 7, 2021
Human Wnt/β-Catenin Regulates Alloimmune Signaling during Allogeneic TransplantationMahinbanu Mammadli, Rebecca Harris, Sara Mahmudlu, et al.
JCI Insight|January 27, 2026
β-Catenin Stabilization Protects Against Alveolar Hemorrhage Through Amphiregulin and BATF-Mediated Regulatory T CellsFiona Mason, Hui Xiong, Ali Mobeen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cellsMichael R Verneris, Arash Arshi, Matthias Edinger, et al.
Frontiers in Immunology|December 16, 2020
Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCTMahinbanu Mammadli, Weishan Huang, Rebecca Harris, et al.
Iscience|April 14, 2021
Targeting SLP76:ITK interaction separates GVHD from GVL in allo-HSCTMahinbanu Mammadli, Weishan Huang, Rebecca Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical studyJohn K Chan, Chad A Hamilton, Michael K Cheung, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|December 23, 2022
TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responsesRebecca Harris, Mahinbanu Mammadli, Shannon Hiner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cellsMobin Karimi, Thai M Cao, Jeanette A Baker, et al.
Blood|June 21, 2008
In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activityRyosei Nishimura, Jeanette Baker, Andreas Beilhack, et al.
Clinical and Translational Medicine|December 17, 2021
Interleukin-2-inducible T-cell kinase (Itk) signaling regulates potent noncanonical regulatory T cellsMahinbanu Mammadli, Rebecca Harris, Liye Suo, et al.
Cancers|August 7, 2021
Human Wnt/β-Catenin Regulates Alloimmune Signaling during Allogeneic TransplantationMahinbanu Mammadli, Rebecca Harris, Sara Mahmudlu, et al.
JCI Insight|January 27, 2026
β-Catenin Stabilization Protects Against Alveolar Hemorrhage Through Amphiregulin and BATF-Mediated Regulatory T CellsFiona Mason, Hui Xiong, Ali Mobeen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cellsMichael R Verneris, Arash Arshi, Matthias Edinger, et al.
Frontiers in Immunology|December 16, 2020
Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCTMahinbanu Mammadli, Weishan Huang, Rebecca Harris, et al.
Iscience|April 14, 2021
Targeting SLP76:ITK interaction separates GVHD from GVL in allo-HSCTMahinbanu Mammadli, Weishan Huang, Rebecca Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical studyJohn K Chan, Chad A Hamilton, Michael K Cheung, et al.
Pageof 3